Literature DB >> 33724390

Delirium and Functional Recovery in Patients Discharged to Skilled Nursing Facilities After Hospitalization for Heart Failure.

Caroline Madrigal1, Jenny Kim1, Lan Jiang1, Jacob Lafo1,2, Melanie Bozzay3,4, Jennifer Primack1,2,4, Stephen Correia1,2,3,5, Sebhat Erqou1,2, Wen-Chih Wu1,2, James L Rudolph1,2,6.   

Abstract

Importance: A substantial number of patients discharged to skilled nursing facilities (SNFs) after heart failure (HF) hospitalization experience regression in function or do not improve. Delirium is one of few modifiable risk factors in this patient population. Therefore, understanding the role of delirium in functional recovery may be useful for improving outcomes. Objective: To assess the association of delirium with 30-day functional improvement in patients discharged to SNFs after HF hospitalization. Design, Setting, and Participants: This retrospective cohort study included patients hospitalized for HF in 129 US Department of Veterans Affairs hospitals who were discharged to SNFs from October 1, 2010, to September 30, 2015. Data were analyzed from June 14 to December 18, 2020. Exposures: Delirium, as determined by the Minimum Data Set (MDS) 3.0 Confusion Assessment Method, with dementia as a covariate, determined via International Classification of Diseases, Ninth Revision (ICD-9) coding. Main Outcomes and Measures: The difference between admission and 30-day MDS 3.0 Activities of Daily Living (ADL) scores.
Results: A total of 20 495 patients (mean [SD] age, 78 [10.3] years; 78.9% White; and 97% male) were included in the analysis. Of the total sample, 882 patients (4.3%) had delirium on an SNF admission. The mean (SD) baseline ADL score on admission to SNF was significantly worse among patients with delirium than without (18.3 [4.7] vs 16.1 [5.2]; P < .001; d = 0.44.). On the 30-day repeated assessment, mean (SD) function (ADL scores) improved for both patients with delirium (0.6 [2.9]) and without delirium (1.8 [3.6]) (P < .001; d = -0.38). In the multivariate adjusted model, delirium was associated with statistically significant lower ADL improvement (difference in ADL score, -1.07; 95% CI, -1.31 to -0.83; P < .001). Conclusions and Relevance: In this retrospective cohort study, patients with HF discharged to SNFs with delirium were less likely to show improvement in function compared with patients without delirium. Findings suggest a potential need to reexamine how and when health care professionals assess delirium in HF patients throughout their hospitalization and SNF course. Identifying and treating delirium for HF patients earlier in their care trajectory may play an important role in improving care and long-term functional outcomes in this population. Future research is warranted to further investigate the association between delirium and functional recovery for HF and other patient populations.

Entities:  

Year:  2021        PMID: 33724390      PMCID: PMC7967078          DOI: 10.1001/jamanetworkopen.2020.37968

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  35 in total

Review 1.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

Review 2.  Interdisciplinary care planning and the written care plan in nursing homes: a critical review.

Authors:  Mary Ellen Dellefield
Journal:  Gerontologist       Date:  2006-02

3.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

4.  Clarifying confusion: the confusion assessment method. A new method for detection of delirium.

Authors:  S K Inouye; C H van Dyck; C A Alessi; S Balkin; A P Siegal; R I Horwitz
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

5.  Outcomes of older people admitted to postacute facilities with delirium.

Authors:  Edward R Marcantonio; Dan K Kiely; Samuel E Simon; E John Orav; Richard N Jones; Katharine M Murphy; Margaret A Bergmann
Journal:  J Am Geriatr Soc       Date:  2005-06       Impact factor: 5.562

6.  Activities of daily living and outcomes in heart failure.

Authors:  Shannon M Dunlay; Sheila M Manemann; Alanna M Chamberlain; Andrea L Cheville; Ruoxiang Jiang; Susan A Weston; Véronique L Roger
Journal:  Circ Heart Fail       Date:  2015-02-25       Impact factor: 8.790

Review 7.  The Confusion Assessment Method: a systematic review of current usage.

Authors:  Leslie A Wei; Michael A Fearing; Eliezer J Sternberg; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

8.  Obesity interacts with cerebral hypoperfusion to exacerbate cognitive impairment in older adults with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Manfred van Dulmen; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Cerebrovasc Dis Extra       Date:  2012-10-25

9.  A hospital-wide evaluation of delirium prevalence and outcomes in acute care patients - a cohort study.

Authors:  Maria Schubert; Roger Schürch; Soenke Boettger; David Garcia Nuñez; Urs Schwarz; Dominique Bettex; Josef Jenewein; Jasmina Bogdanovic; Marina Lynne Staehli; Rebecca Spirig; Alain Rudiger
Journal:  BMC Health Serv Res       Date:  2018-07-13       Impact factor: 2.655

10.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.

Authors:  Domenico Inzitari; Giovanni Pracucci; Anna Poggesi; Giovanna Carlucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni
Journal:  BMJ       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.